|
WHAT'S NEW IN PHARMA eNEWSLETTER
|
Sign up for our newsletter today and find out what other 70,000 pharma professionals already know.
|
View sample e-newsletter here
|
|
|
| WHAT'S NEW IN THE MEDIA | Roche staples Aileron Deal
Aileron Therapeutics (www.aileronrx.com/) and Roche have entered into a collaboration to discover, develop and commercialise a new class of drugs called Stapled Peptide Therapeutics. As part of this agreement, Roche will work with Aileron to develop drug candidates against up to five undisclosed targets selected from Roche’s key therapeutic areas, which include oncology, virology, inflammation | UK Drug pricing policy questioned by NHS drugs adviser
Sir Michael Rawlins, Chairman of NICE (www.nice.org.uk/), has said that he believes it would often benefit the NHS if pharmaceutical companies were to initially offer deeper discounts on their drugs, rather than devise sophisticated alternatives such as rebates. He added that so-called patient access schemes were complicated for NHS trusts to implement due to factors such as difficulties of... | 90Y-resin microspheres help for patients with inoperable cancers
Using the innovative technique of radioembolisation to treat patients with inoperable colorectal cancer liver metastases who have failed all standard-of-care chemotherapy options can more than double the time until their disease progresses, according to the final results of a Phase III randomised controlled trial published in the prestigious Journal of Clinical Oncology.The prospective, randomised.. | Chroma Therapeutics receives milestone payment from GSK
Chroma Therapeutics has advanced its novel macrophage-targeted HDAC inhibitor, CHR-5154, into preclinical development, triggering an undisclosed milestone payment from partner GlaxoSmithKline (GSK). HDAC inhibitors have been demonstrated to have broad anti-inflammatory activity, in addition to their activity in a variety of cancers, and may be useful for the treatment of disorders such as... | Bay Area Biotech and the Rest of the World
Gail Maderis is President & CEO of BayBio, the industry organization representing and supporting Northern California’s life science community. Here she gives her views on how the US and California are ranked in the biotech world. Recently, Newsweek columnist Fareed Zakaria told an audience of biotechnology executives that America’s foothold as the pre-eminent technology innovator may be... |
UBM JAPAN PHARMA EVENTS GROW DESPITE AIR TRAVEL DISRUPTIONS
Despite significant international travel restrictions due to the recent Icelandic volcanic cloud, leading events organiser UBM International Media and sister company UBM Japan Co. Ltd. today announced a record visitor attendance of 14,435 at its 2010 Japanese Pharma events cluster, which took place from 21-23 April at Tokyo’s Big Sight Exhibition Center.
CPhI Conferences happening in 2010
Taking Pharma sourcing strategies to the next level, CPhI’s annual sourcing conference PharmaSource will exclusively reveal the next generation of sourcing strategies being developed and deployed by the major players in the Pharma industry, while API Global Sourcing Strategies will arm you with all the market intelligence you need to fully mitigate the threat to your supply chain security, whilst sourcing the most cost effective APIs available. |
Privacy Statement | Copyright © 2010 UBM International Media BV, All rights reserved.
|
|
|
